Renaissance Technologies UNITED THERAPEUTICS CORP DEL ownership

UNITED THERAPEUTICS CORP DEL's ticker is UTHR and the CUSIP is 91307C102. A total of 448 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.

Renaissance Technologies ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q3 2022$533,964
-18.9%
2,550,214
-8.7%
0.76%
-3.1%
Q2 2022$658,282
+32.7%
2,793,591
+1.0%
0.78%
+33.8%
Q1 2022$496,107
-21.3%
2,765,213
-5.2%
0.58%
-25.8%
Q4 2021$630,347
+12.8%
2,917,191
-3.7%
0.78%
+8.6%
Q3 2021$559,017
+0.2%
3,028,591
-2.6%
0.72%
+3.6%
Q2 2021$557,999
+4.0%
3,110,191
-3.0%
0.70%
+4.5%
Q1 2021$536,534
-2.0%
3,207,591
-11.1%
0.67%
+12.1%
Q4 2020$547,551
+46.2%
3,607,291
-2.7%
0.60%
+59.1%
Q3 2020$374,611
-16.9%
3,709,018
-0.5%
0.37%
-3.9%
Q2 2020$450,945
+32.5%
3,726,818
+3.8%
0.39%
+17.5%
Q1 2020$340,443
+9.0%
3,590,223
+1.3%
0.33%
+37.9%
Q4 2019$312,194
+21.9%
3,544,433
+10.3%
0.24%
+10.6%
Q3 2019$256,179
+7.9%
3,212,278
+5.6%
0.22%
+3.8%
Q2 2019$237,379
-9.8%
3,040,978
+35.7%
0.21%
-12.6%
Q1 2019$263,117
+10.0%
2,241,778
+2.0%
0.24%
-8.8%
Q4 2018$239,229
-3.8%
2,196,778
+13.0%
0.26%
+2.3%
Q3 2018$248,609
-28.6%
1,944,078
-37.1%
0.26%
+34.7%
Q2 2018$348,431
+102.2%
3,090,078
+101.5%
0.19%
+1.1%
Q1 2018$172,347
-20.3%
1,533,878
+4.9%
0.19%
-21.3%
Q4 2017$216,359
+45.0%
1,462,378
+14.9%
0.24%
+35.8%
Q3 2017$149,183
+37.3%
1,273,000
+52.0%
0.18%
+26.6%
Q2 2017$108,662
+58.6%
837,600
+65.5%
0.14%
+44.8%
Q1 2017$68,529
+13.4%
506,200
+20.2%
0.10%0.0%
Q4 2016$60,413
+31.2%
421,200
+8.0%
0.10%
+18.5%
Q3 2016$46,063
+7.6%
390,100
-3.5%
0.08%
-1.2%
Q2 2016$42,823
-19.0%
404,300
-14.8%
0.08%
-18.8%
Q1 2016$52,882
-38.8%
474,578
-14.0%
0.10%
-46.3%
Q4 2015$86,461
-24.0%
552,078
-36.3%
0.19%
-30.6%
Q3 2015$113,756
-19.4%
866,778
+6.8%
0.27%
-15.8%
Q2 2015$141,174
+83.4%
811,578
+81.8%
0.32%
+96.3%
Q1 2015$76,992
+221.0%
446,500
+141.0%
0.16%
+182.8%
Q4 2014$23,986
+7738.6%
185,238
+7689.7%
0.06%
+5700.0%
Q3 2014$306
-98.6%
2,378
-99.1%
0.00%
-98.1%
Q2 2014$22,342
-17.5%
252,478
-12.3%
0.05%
-20.0%
Q1 2014$27,075
+6.8%
287,940
+28.4%
0.06%
+6.6%
Q4 2013$25,361
-27.0%
224,278
-49.1%
0.06%
-27.4%
Q3 2013$34,755
-10.6%
440,778
-25.3%
0.08%
-17.6%
Q2 2013$38,859590,3780.10%